NCT04646694View on ClinicalTrials.gov

The Ketamine for Acute Postoperative Analgesia (KAPA) Trial

PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 17, 2020

Primary Completion Date

March 31, 2023

Study Completion Date

June 30, 2023

Conditions
Postoperative Pain
Interventions
DRUG

Ketamine

The use of oral Ketamine in this study is experimental.This study will look at how effective and safe Ketamine.

OTHER

Placebo

A placebo is given in this study to reduce the chances of believing that pain after surgery is getting better because one is receiving oral Ketamine

Trial Locations (1)

M5T 2S8

TWH/UHN, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER

NCT04646694 - The Ketamine for Acute Postoperative Analgesia (KAPA) Trial | Biotech Hunter | Biotech Hunter